Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cannata

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Oncology Reports|May 21, 2011
Cisplatin plus vp16 as salvage treatment for advanced breast-carcinoma resistant or recurrent after 1st line chemotherapy for metastatic diseaseB Ferrero, V Gebbia, G Cannata, et al.
Cancer|October 1, 1994
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trialV Gebbia, G Cannata, A Testa, et al.
Minerva Chirurgica|January 1, 1990
[Our experience in the use of somatostatin in upper digestive hemorrhages]E Ciconi, C Botta, R Capoluongo, et al.
American Journal of Clinical Oncology|August 1, 1995
Vinorelbine plus cisplatin in recurrent or previously untreated unresectable squamous cell carcinoma of the head and neckV Gebbia, A Testa, C Di Gregorio, et al.
Oncology Reports|May 20, 2011
Second line chemotherapy for metastatic colorectal carcinomaV Gebbia, A Testa, G Cannata, et al.
Journal of Chemotherapy (Florence, Italy)|April 1, 1994
Combination chemotherapy of 5-fluorouracil, epidoxorubicin and mitomycin C in the palliative treatment of locally advanced and/or metastatic adenocarcinoma of the stomachV Gebbia, A Testa, R Valenza, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|September 1, 1994
Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neckV Gebbia, R Valenza, A Testa, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1992
Weekly 5-fluorouracil and folinic acid plus escalating doses of cisplatin with glutathione protection in patients with advanced head and neck cancerV Gebbia, R Valenza, A Testa, et al.
Oncology|November 1, 1993
A phase II study of levofolinic acid and 5-fluorouracil plus cisplatin in patients with advanced head and neck squamous cell carcinomaV Gebbia, A Testa, R Valenza, et al.
Minerva Chirurgica|April 30, 1984
[The importance of the type of surgical exeresis on survival in breast cancer. Possibility of polychemotherapy]C Orecchia, F Sigaudo, L Ardizzone, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Oncology Reports|May 21, 2011
Cisplatin plus vp16 as salvage treatment for advanced breast-carcinoma resistant or recurrent after 1st line chemotherapy for metastatic diseaseB Ferrero, V Gebbia, G Cannata, et al.
Cancer|October 1, 1994
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trialV Gebbia, G Cannata, A Testa, et al.
Minerva Chirurgica|January 1, 1990
[Our experience in the use of somatostatin in upper digestive hemorrhages]E Ciconi, C Botta, R Capoluongo, et al.
American Journal of Clinical Oncology|August 1, 1995
Vinorelbine plus cisplatin in recurrent or previously untreated unresectable squamous cell carcinoma of the head and neckV Gebbia, A Testa, C Di Gregorio, et al.
Oncology Reports|May 20, 2011
Second line chemotherapy for metastatic colorectal carcinomaV Gebbia, A Testa, G Cannata, et al.
Journal of Chemotherapy (Florence, Italy)|April 1, 1994
Combination chemotherapy of 5-fluorouracil, epidoxorubicin and mitomycin C in the palliative treatment of locally advanced and/or metastatic adenocarcinoma of the stomachV Gebbia, A Testa, R Valenza, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|September 1, 1994
Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neckV Gebbia, R Valenza, A Testa, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1992
Weekly 5-fluorouracil and folinic acid plus escalating doses of cisplatin with glutathione protection in patients with advanced head and neck cancerV Gebbia, R Valenza, A Testa, et al.
Oncology|November 1, 1993
A phase II study of levofolinic acid and 5-fluorouracil plus cisplatin in patients with advanced head and neck squamous cell carcinomaV Gebbia, A Testa, R Valenza, et al.
Minerva Chirurgica|April 30, 1984
[The importance of the type of surgical exeresis on survival in breast cancer. Possibility of polychemotherapy]C Orecchia, F Sigaudo, L Ardizzone, et al.
Pageof 4